Polymorphisms in the CYP19 gene confer increased risk for Alzheimer disease
- PMID: 15079018
- DOI: 10.1212/01.wnl.0000118208.16939.60
Polymorphisms in the CYP19 gene confer increased risk for Alzheimer disease
Abstract
Background: Brain aromatase may be neuroprotective by increasing the local estrogen levels in injured neurons. Aromatase is encoded by the CYP19 gene located at 15q21.1, a chromosomal region in linkage disequilibrium (LD) with Alzheimer disease (AD) in this sample.
Objective: To investigate whether nine single-nucleotide polymorphisms (SNP) spanning the CYP19 gene were associated with AD.
Methods: Three hundred ninety-four patients were compared with 469 nondemented control subjects using single-locus and haplotype approaches. Haplotypes were identified using the expectation/maximization algorithm and latent class analysis, which included additional information on age, sex, and APOE polymorphism.
Results: Allelic and genotypic frequencies for three adjacent SNP differed between AD and control groups. Both haplotype approaches identified an approximately 60% increase (p = 0.02) in the risk of AD for one haplotype and similar levels of excess risk irrespective of APOE polymorphism and gender.
Conclusion: Genetic variation in the brain aromatase gene may modify the risk for AD.
Similar articles
-
CYP19 haplotypes increase risk for Alzheimer's disease.J Med Genet. 2006 Aug;43(8):e42. doi: 10.1136/jmg.2005.039461. J Med Genet. 2006. PMID: 16882736 Free PMC article.
-
Genetic variation of CYP19 (aromatase) gene influences age at onset of Alzheimer's disease in women.Dement Geriatr Cogn Disord. 2009;27(6):513-8. doi: 10.1159/000221832. Epub 2009 May 29. Dement Geriatr Cogn Disord. 2009. PMID: 19478482
-
A comprehensive haplotype analysis of CYP19 and breast cancer risk: the Multiethnic Cohort.Hum Mol Genet. 2003 Oct 15;12(20):2679-92. doi: 10.1093/hmg/ddg294. Epub 2003 Aug 27. Hum Mol Genet. 2003. PMID: 12944421
-
SNPing away at complex diseases: analysis of single-nucleotide polymorphisms around APOE in Alzheimer disease.Am J Hum Genet. 2000 Aug;67(2):383-94. doi: 10.1086/303003. Epub 2000 Jun 21. Am J Hum Genet. 2000. PMID: 10869235 Free PMC article.
-
Aromatase enzyme and Alzheimer's disease.Minerva Endocrinol. 2006 Mar;31(1):61-73. Minerva Endocrinol. 2006. PMID: 16498364 Review.
Cited by
-
Variants in CYP17 and CYP19 cytochrome P450 genes are associated with onset of Alzheimer's disease in women with down syndrome.J Alzheimers Dis. 2012;28(3):601-12. doi: 10.3233/JAD-2011-110860. J Alzheimers Dis. 2012. PMID: 22057025 Free PMC article.
-
Aromatase and interleukin-10 genetic variants interactively modulate Alzheimer's disease risk.J Neural Transm (Vienna). 2008 Jun;115(6):863-7. doi: 10.1007/s00702-008-0028-5. Epub 2008 Feb 26. J Neural Transm (Vienna). 2008. PMID: 18299793
-
In vivo visualization of aromatase in animals and humans.Front Neuroendocrinol. 2016 Jan;40:42-51. doi: 10.1016/j.yfrne.2015.10.001. Epub 2015 Oct 9. Front Neuroendocrinol. 2016. PMID: 26456904 Free PMC article. Review.
-
Estrogen receptor-Beta variants are associated with increased risk of Alzheimer's disease in women with down syndrome.Dement Geriatr Cogn Disord. 2011;32(4):241-9. doi: 10.1159/000334522. Epub 2011 Dec 8. Dement Geriatr Cogn Disord. 2011. PMID: 22156442 Free PMC article.
-
CYP19 haplotypes increase risk for Alzheimer's disease.J Med Genet. 2006 Aug;43(8):e42. doi: 10.1136/jmg.2005.039461. J Med Genet. 2006. PMID: 16882736 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
